Meds & supplements › Xanomeline
Medicine · Cholinergic Muscarinic Agonist
COBENFY is indicated for the treatment of schizophrenia in adults.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
The following clinically significant adverse reactions are described elsewhere in the labeling:
COBENFY is contraindicated in patients with:
sofidex [Internet]. Daloreum; c2026. Xanomeline; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/xanomeline
sofidex. (2026, August 3). Xanomeline. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/xanomeline
Xanomeline. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/xanomeline
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.